A phase I dose escalation trial of MAGE-A3- and HPV16-specific peptide immunomodulatory vaccines in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN)
Titel:
A phase I dose escalation trial of MAGE-A3- and HPV16-specific peptide immunomodulatory vaccines in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN)
Auteur:
Zandberg, Dan P. Rollins, Sandra Goloubeva, Olga Morales, Robert E. Tan, Ming Taylor, Rodney Wolf, Jeffrey S. Schumaker, Lisa M. Cullen, Kevin J. Zimrin, Ann Ord, Robert Lubek, Joshua E. Suntharalingam, Mohan Papadimitriou, John C. Mann, Dean Strome, Scott E. Edelman, Martin J.